Afinitor (Everolimus) for rare pancreatic cancer approved by FDA (Medical News Today, 8 May 2011)

Vitamin D plays role in prevention of RSV infections in infants (Medical News Today, 9 May 2011)

Astellas Pharma and Medivation announce initiation of phase 2 clinical trial of MDV3100 in hormone-naive prostate cancer patients (Biospace, 5 May 2011)

10 May 2011

Pharmaceutical companies Astellas Pharma and Medivation have announced phase 2 of the clinical trial of MDV3100, an androgen receptor antagonist which is being trialled as the first hormonal treatment of patients with prostate cancer.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read